Home / Medical Devices / Breast Biopsy Devices Market By Products (Needle Based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), Type (Fine Needle Aspiration, Core Needle, Vacuum Assisted Breast, Incisional And Excisional), Guidance Modality (Stereotactic X-Ray, Ultrasound, MRI, Without Imaging) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

Breast Biopsy Devices Market By Products (Needle Based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), Type (Fine Needle Aspiration, Core Needle, Vacuum Assisted Breast, Incisional And Excisional), Guidance Modality (Stereotactic X-Ray, Ultrasound, MRI, Without Imaging) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

Published: Mar 2016 | Report Code: 57742-03-16

Breast biopsy devices market has witnessed a phenomenal shift in nature over the past few decades. The ability to biopsy both non-palpable and palpable breast abnormalities have been among the biggest advancements in breast cancer diagnosis. However, the noteworthy development in this field is the evolution in biopsy methods. This report studies the global breast biopsy devices market in terms of product types, biopsy type, type of guidance system used for performing breast biopsy and geographical distribution.

Based on the products types this market is segmented into needle based biopsy guns, biopsy guidance systems, biopsy forceps, biopsy needles and others equipment (Curettes, Punches, Markers). The guidance systems market for breast biopsy devices market is categorized as stereotactic X-ray guided biopsy, ultrasound guided biopsy, MRI guided biopsy and without imaging guidance biopsy.

The various breast biopsy types analyzed in this report are fine needle aspiration biopsy (FNAB), core needle biopsy (CNB), vacuum-assisted breast biopsy (VABB), and incisional and excisional biopsy. The geographical distribution of the global breast biopsy devices market considered in this study encompasses regional markets such as North America, Europe, Asia Pacific, Middle East and North Africa and rest of the world.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Breast Biopsy Devices Market, by Biopsy Type, 2015 (USD Mn)
2.2 Breast Biopsy Devices Market Share, by Product Type, 2015 & 2022 (Value %)
2.3 Breast Biopsy Devices Market, by Guidance Type, 2015 (USD Mn)
2.4 Breast Biopsy Devices Market Share, by Geography, 2015 (Value %)

Chapter 3 Breast Biopsy Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.1.1 Breast Cancer Estimated Incidence & Mortality, Worldwide (2012)
3.2 Drivers
3.2.1 Population Aging Contributing to Mandate for Cancer Diagnostics
3.2.1.1 Age-specific Breast Cancer Rates: United States
3.2.1.2 Age Statistics Above 65, by Key Countries, 2015 - 2030
3.2.2 Excessive Disease Prevalence
3.2.2.1 Estimated Incidence, Mortality and Prevalence of Breast Cancer, Worldwide, 2012
3.3 Challenges
3.3.1 High Costs of Biopsy May Constrain Growth
3.3.2 Susceptibility to Radiation Exposure
3.4 Future Prospects
3.4.1 Integrated Breast Centers
3.5 Impact Analysis of Drivers and Challenges During the Forecast Period
3.6 Attractive Investment Proposition

Chapter 4 Global Breast Biopsy Market Analysis, by Biopsy Type
4.1 Preface
4.2 Fine Needle Aspiration Biopsy (FNAB)
4.3 Core Needle Biopsy (CNB)
4.4 Vacuum Assisted Breast Biopsy (VABB)
4.5 Incisional and Excisional Breast Biopsy

Chapter 5 Global Breast Biopsy Market Analysis, by Products
5.1 Preface
5.2 Needle Based Biopsy Guns
5.3 Biopsy Guidance Systems
5.4 Biopsy Forceps
5.5 Biopsy Needles
5.6 Others (Curettes, Punches, Markers)

Chapter 6 Breast Biopsy Devices Market, by Guidance Modality
6.1 Preface
6.2 Stereotactic X-ray Guided Biopsy
6.3 Ultrasound Guided Biopsy
6.4 MRI Guided Biopsy
6.5 Without Imaging Guidance Biopsy

Chapter 7 Breast Biopsy Devices Market, by Geography
7.1 Preface
7.2 North America
7.3 Europe
7.4 Asia Pacific
7.5 Middle East and North Africa (MENA)
7.6 Rest of the World (RoW)

Chapter 8 Future Growth Advocacies

Chapter 9 Company Profiles
9.1 Hologic
9.1.1 Business Description
9.1.2 Financial Health and budget allocation
9.1.3 Product Positions/Portfolio
9.1.4 Key Competitors
9.1.5 News Coverage
9.2 Becton, Dickinson and Company
9.2.1 Business Description
9.2.2 Financial Health and Budget Allocation
9.2.3 Product Positions/Portfolio
9.2.4 Key Competitors
9.2.5 News Coverage
9.3 C.R. Bard, Inc.
9.3.1 Business Description
9.3.2 Financial Health and Budget Allocation
9.3.3 Product Positions/Portfolio
9.3.4 Key Competitors
9.3.5 News Coverage
9.4 Mammotome (Devicor Medical Products, Inc.)
9.4.1 Business Description
9.4.2 Financial Health and budget allocation
9.4.3 Product Positions/Portfolio
9.4.4 Key Competitors
9.4.5 News Coverage

List of Tables

TABLE 1 Impact Indicators
TABLE 2 Impact Analysis of Drivers and Restraints
TABLE 3 Global Breast Biopsy Devices Market, by Biopsy Type, 2013 – 2022 (USD Mn)
TABLE 4 Global Breast Biopsy Devices Market, by Product Type, 2013 – 2022 (USD Mn)
TABLE 5 Global Breast Biopsy Devices Market, by Guidance Modality, 2013 – 2022 (USD Mn)
TABLE 6 Global Breast Biopsy Devices Market, by Geography, 2013 – 2022 (USD Mn)

List of Figures

FIG. 1 Breast Biopsy Devices: Market Segmentation
FIG. 2 Breast Biopsy Devices Market, by Biopsy Type, 2015 (USD Mn)
FIG. 3 Breast Biopsy Devices Market Share, by Product Type, 2015 & 2022 (Value %)
FIG. 4 Breast Biopsy Devices Market, by Guidance Type, 2015 (USD Mn)
FIG. 5 Breast Biopsy Devices Market Share, by Geography, 2015 (Value %)
FIG. 6 Breast Cancer Estimated Incidence & Mortality, Worldwide (2012)
FIG. 7 Age-specific Breast Cancer Rates: United States
FIG. 8 Age Statistics Above 65, by Key Countries, 2015 - 2030
FIG. 9 Estimated Incidence, Mortality and Prevalence of Breast Cancer, Worldwide, 2012
FIG. 10 Attractive Investment Proposition, Breast Biopsy Devices Market, 2015
FIG. 11 Exhibit 1: Diagnostic Value of FNAB in Breast Masses
FIG. 12 Global Fine Needle Aspiration Biopsy (FNAB) Market Revenue, 2013 – 2022 (USD Mn)
FIG. 13 Exhibit 1: Diagnostic Value of Core Needle Biopsy in Breast Lesions
FIG. 14 Global Core Needle Biopsy (CNB) Market Revenue, 2013 – 2022 (USD Mn)
FIG. 15 Global Vacuum-assisted Breast Biopsy (VABB) Market Revenue, 2013 – 2022 (USD Mn)
FIG. 16 Global Incisional and Excisional Breast Biopsy Market Revenue, 2013 – 2022 (USD Mn)
FIG. 17 Global Needle Based Breast Biopsy Guns Market Revenue, 2013 – 2022 (USD Mn)
FIG. 18 Global Breast Biopsy Guidance Systems Market Revenue, 2013 – 2022 (USD Mn)
FIG. 19 Global Breast Biopsy Forceps Market Revenue, 2013 – 2022 (USD Mn)
FIG. 20 Global Breast Biopsy Needles Market Revenue, 2013 – 2022 (USD Mn)
FIG. 21 Global Other Breast Biopsy Equipment and Accessories Market Revenue, 2013 – 2022 (USD Mn)
FIG. 22 Global Stereotactic X-ray Guided Breast Biopsy Market Revenue, 2013 – 2022 (USD Mn)
FIG. 23 Global Ultrasound Guided Breast Biopsy Market Revenue, 2013 – 2022 (USD Mn)
FIG. 24 Global MRI Guided Breast Biopsy Market Revenue, 2013 – 2022 (USD Mn)
FIG. 25 Global Without Guidance Breast Biopsy Market Revenue, 2013 – 2022 (USD Mn)
FIG. 26 North America Breast Biopsy Market Revenue, 2013 – 2022 (USD Mn)
FIG. 27 Europe Breast Biopsy Market Revenue, 2013 – 2022 (USD Mn)
FIG. 28 Asia Pacific Breast Biopsy Market Revenue, 2013 – 2022 (USD Mn)
FIG. 29 Middle East and North Africa Breast Biopsy Market Revenue, 2013 – 2022 (USD Mn)
FIG. 30 Rest of the World Breast Biopsy Market Revenue, 2013 – 2022 (USD Mn)

Based on the type of equipment employed for breast biopsy, the global breast biopsy devices market is segmented as follows:

  • Needle Based Biopsy Guns
  • Biopsy Guidance Systems
  • Biopsy Forceps
  • Biopsy Needles
  • Others (Curettes, Punches, Markers)

Breast Biopsy

In the base year 2015, biopsy guidance systems held the dominant market position and it is expected that the trend shall continue through the forecast period. Cost of equipment and the associated long equipment life, and proven effectiveness in the offering closest accurate tissue extraction and thus diagnosis are the prie factors contributing to the dominance of the segment. On the other hand, the biopsy needles segment will experience the fastest market growth during the forecast period. The market growth of the segment is majorly contributed by the faster trade of the product coupled with the growing demand for disposable product variants in the developed markets.

Fine needle aspiration, core needle biopsy, vacuum-assisted breast biopsy, and incisional and excisional breast biopsy are the prime methods employed for performing breast biopsy.

Breast Biopsy Devices Market

Earlier, open surgical breast biopsies were considered as the gold standard, until the advent of fine needle aspiration. Furthermore drawbacks of fine needle aspiration biopsy such as high rate of negative results, challenged accuracy in determining ER, PR, and HER-2 status of samples and lack of standard interpretation parameters for determining fine needle aspiration led to the increased preference for solutions such as core needle biopsy and vacuum-assisted breast biopsy.

At present, vacuum-assisted breast biopsy segment is the fastest growing biopsy type among the rest, as the solution easily overcomes the drawbacks of fine needle aspiration biopsy and core needle biopsy. The efficiency of vacuum-assisted breast biopsy in effectively determining Her-2, ER and PR status with the closest accuracy is yet another factor contributing the segment growth.

For the purpose of this study, the global breast biopsy devices market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and North Africa (MENA)
  • Rest of the World

Breast Biopsy Devices Market

In the base year 2015, North America and Europe together captured more than 60% of the global market revenue. The regions have ensured their lead in terms of market position due to factors such as rapid adoption of latest medical technologies, higher awareness about disease prevention and early diagnosis, large targeted patient population pool and others.

Existence of better and well structured reimbursement policies is also a prime influencer to the dominance of North America in the global market. On the other hand, Asia Pacific will experience the fastest market growth during the forecast period. The alarming incidence rate coupled with gradually rising awareness about breast cancer and the growing preference for minimally invasive diagnostic solutions are the major contributing factors to the growth of Asia Pacific market during 2016-2022.

Image guided surgeries are becoming the latest trend in the surgical market. The same inclination is being observed in the breast biopsy devices market. Based on the guidance systems employed, the breast biopsy devices market is segmented into:

  • Stereotactic X-ray Guided Biopsy
  • Ultrasound Guided Biopsy
  • MRI Guided Biopsy
  • Without Imaging Guidance Biopsy

breast Biopsy

Stereotactic X-ray guided breast biopsy is the most widely adopted type of guided breast biopsy. It has been viewed as an advanced alternative to open surgical biopsies. Also, this modality is opined to be a cost-effective alternative to advanced guided biopsy methods such as MRI guided biopsy, particularly in the developing markets, where cost is an important criteria determining the overall market trends. On the other hand, MRI guided breast biopsy is being increasingly adopted in developed markets of North America and Western Europe, where the overall awareness about health and safety is higher.

The diagnosis and treatment of breast cancer has been transformed, from the aggressive treatment of what was thought to begin as a local disease to a more evolved approach to what is now known to be a systemic disease. Years ago, the only breast biopsy option available was an open breast procedure. As technology developed, the mammogram became more important, not only as a tool for screening abnormalities but also as a diagnosis device for breast disease. Today, technology has rapidly progressed to the point at which most breast biopsies are image-guided, with few breast biopsies requiring an operating room for initial definitive diagnosis.

Majority of the minimally invasive breast biopsies are currently performed using image guidance solutions such as ultrasound, mammogram and MRI, for both palpable and non-palpable lesions. Image guidance improves the accuracy of less invasive biopsies, thus taking over the demand for open surgical biopsies. Furthermore, the latest tissue acquisition systems obtain core tissue samples instead of individual cells retrieved through fine needle aspiration. Spring loaded systems have been proven to be more efficient and dependable than fine needle aspiration. Further advanced systems such as vacuum-assisted breast biopsy devices are opined to be more efficient and reliable biopsy solutions.

A major improvement over conventional core biopsy has been the Mammotome system (introduced in 1994). Mammotome used vacuum assistance for tissue aspiration. Mammotome allows extraction of multiple cores during single needle insertion. Further significant improvement over the Mammotome system has been the ATEC breast biopsy system. ATEC is claimed to be compatible with all stereotactic and ultrasound imaging systems, and is also compatible with MRI guidance systems. ATEC was the first vacuum assisted breast biopsy device with compatibility with MRI imaging system. Other less known and experimental techniques include galactography, positron emission tomography (PET) and ductal lavage.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients